Global Small Molecule API Market, by API Type (Artificial, and Natural), by Category (Analgesic, Anesthetics, Anticonvulsants, Antimetabolites, Antibacterial, Alkylating Agents, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) was valued at US$ 126.6 billion in 2017, and is projected to exhibit a CAGR of 9.1% over the forecast period (2018 – 2026).
Strong research and development in API by market players to augment the market growth Key players in the market are focused on research and development in order to develop novel products to address the critical and unmet needs of patients. For instance, according to India Brand Equity Foundation (IBEF), investment in research and development by India-based pharmaceutical companies increased (in term of sales) from 5.3% to 8.5% from 2012 to 2018. Similarly, as per U.S. Food and Drug Administration (FDA), in March 2016, there were around 37 drugs in clinical development for treating serious bacterial infections. These drugs are intended to be primarily launched in the U.S. Moreover, increasing prevalence of various types of cancers worldwide is expected to boost the market growth. International Agency for Research on Cancer published the GLOBOCAN 2018 report, which focuses on geographic variability of cancer incidence and mortality rate across 20 world regions. The report projected 18.1 million new cancer cases (17.0 million excluding non-melanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding non-melanoma skin cancer) in 2018.
Browse 34 Market Data Tables and 23 Figures spread through 261 Pages and in-depth TOC on ‘Small Molecule API Market’- Global Forecast to 2026, by API Type (Artificial, and Natural), by Category (Analgesic, Anesthetics, Anticonvulsants, Antimetabolites, Antibacterial, Alkylating Agents, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in the small molecule API market, click the link below:
Key players in the market are focused on adopting strategies such as mergers and acquisitions to enhance their product portfolio. In October 2017, CordenPharma announced acquisition of Pfizer Inc., a manufacturing facility of API Hospira in Colorado, U.S. This acquisition strengthened the CordenParma’s position, as a leading Contract Development & Manufacturing Organization (CDMO).
Key Takeaways of the Small Molecule API Market:
Joining thousands of companies around the world committed to making the Excellent Business Solutions.